Overview

Photosensitization Study in Androgenetic Alopecia

Status:
Completed

Trial end date:
2016-06-27

Target enrollment:

Participant gender:

Summary

This study evaluates the potential for induction of photosensitization by P-3074 0.25% finasteride cutaneous solution compared to that of placebo vehicle cutaneous solution and a negative control (0.9% sodium chloride, NaCl)

Phase:

Phase 1

Details

Lead Sponsor:

Polichem S.A.

Treatments:

Finasteride
Pharmaceutical Solutions